GSK reports strong Q2 earnings, reaffirms FY2026 outlook

GSK announced its Non-GAAP EPS of £0.51, beating estimates by £0.02, and revenue of £8.41 billion, surpassing expectations by £4.05 billion, while reaffirming its financial outlook for 2026.